ClinicalTrials.govpublic full text
Phase 1 Study of Tremelimumab, Durvalumab, High-dose Chemotherapy, + Autologous Stem Cell Transplant
multiple myeloma, autologous stem cell transplant, hdt/asct, ctla-4, pd-l1, peripheral blood mononuclear cells, pbmc, asct, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 968687
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.